Fundraising FoxHookipa Pharma
DefunctNew York, US · Founded 2017 · Delaware corporation · 2 known investors
Find your way into Hookipa Pharma
Sign up to see every warm intro you have to Hookipa Pharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Hookipa Pharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
HOOKIPA Pharma was a clinical-stage biopharmaceutical company developing immunotherapies based on its proprietary arenavirus platform to target T cells against cancer and infectious diseases like HBV, HIV, and HPV.
Founders & leadership
JA
Joern AldagExecutive
RK
Reinhard KanderaExecutive
PL
Paul-Henri LambertNamed on SEC filing
MK
Michael KellyNamed on SEC filing
JO
Julie O'NeillNamed on SEC filing
SV
Sander van DeventerNamed on SEC filing
Board
CL
GS
JV
Jan van de WinkelBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$37.4M disclosed across 1 round · 2019
▶$37.4MraisedFeb 2019 · 9 investors · PharmaceuticalsRule 506(b)
▶$37.4MraisedFeb 2019 · 9 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Joern AldagExecutive Officer, Director
- Christoph LengauerDirector
- Paul-Henri LambertDirector
- Jan van de WinkelDirector
- Michael KellyDirector
- Reinhard KanderaExecutive Officer, Director
- Graziano SeghezziDirector
- Julie O'NeillDirector
- Sander van DeventerDirector
- Amount sold
- $37.4M
- First sale
- Feb 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Hookipa Pharma do?
- HOOKIPA Pharma was a clinical-stage biopharmaceutical company developing immunotherapies based on its proprietary arenavirus platform to target T cells against cancer and infectious diseases like HBV, HIV, and HPV.
- Who are Hookipa Pharma's investors?
- Hookipa Pharma's investors include Sofinnova Partners, Third Rock Ventures.
- How much funding has Hookipa Pharma raised?
- Hookipa Pharma has disclosed $37.4M raised across 1 round.
- Where is Hookipa Pharma headquartered?
- Hookipa Pharma is headquartered in New York, US.